# Biomarkers in Blood Samples From Patients With Refractory Non-Small Cell Lung Cancer Previously Treated With Sorafenib Tosylate

> **NCT01124669** · — · COMPLETED · sponsor: **ECOG-ACRIN Cancer Research Group** · enrollment: 80 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **GENETIC:** DNA analysis
- **GENETIC:** mutation analysis
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT01124669
- **Lead sponsor:** ECOG-ACRIN Cancer Research Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06-13
- **Primary completion:** 2010-07-13
- **Final completion:** 2010-07-13
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2017-05-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01124669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01124669, "Biomarkers in Blood Samples From Patients With Refractory Non-Small Cell Lung Cancer Previously Treated With Sorafenib Tosylate". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01124669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*